|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.36 USD | -1.13% |
|
+9.36% | +14.77% |
| 06-30 | FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications | RE |
| 06-29 | Incyte Corporation(NasdaqGS:INCY) dropped from Russell Midcap Growth Benchmark | CI |
| Market Cap | 22.91B 20.06B 18.51B 17.28B 32.51B 2,168B 33.12B 222B 86.15B 1,069B 86.06B 84.13B 3,725B | P/E 2026 * |
16.5x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.89B 15.66B 14.46B 13.49B 25.39B 1,693B 25.86B 173B 67.28B 834B 67.21B 65.69B 2,909B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 2.58x |
| Free-Float |
98.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | -1.13% | ||
| 1 week | +9.36% | ||
| Current month | +17.18% | ||
| 1 month | +17.18% | ||
| 3 months | +25.54% | ||
| 6 months | +14.17% | ||
| Current year | +14.77% |
| 1 week | 104.49 |  | 115.56 |
| 1 month | 92.18 | | 115.56 |
| Current year | 89.25 | | 115.56 |
| 1 year | 66.83 | | 115.56 |
| 3 years | 50.27 | | 115.56 |
| 5 years | 50.27 | | 115.56 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 25/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 03/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 25/06/2025 |
| Director/Board Member | 72 | 19/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 19/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | +9.36% | +65.80% | +83.28% | 22.91B | |
| -1.31% | +1.80% | +19.68% | -11.98% | 64.28B | |
| -0.57% | +5.82% | +53.94% | +227.66% | 57.29B | |
| -3.94% | +39.10% | +39.10% | +39.10% | 43.45B | |
| -0.56% | +1.65% | -51.04% | -58.77% | 38.02B | |
| -0.26% | +8.19% | +71.37% | -23.42% | 31.98B | |
| +0.47% | +18.00% | +157.84% | -42.65% | 27.66B | |
| -0.56% | +5.64% | +2.91% | +174.96% | 17.74B | |
| -0.13% | +3.87% | +62.33% | +122.76% | 16.45B | |
| +3.43% | +8.07% | +66.03% | +338.38% | 14.1B | |
| Average | -0.53% | +6.87% | +48.80% | +84.93% | 33.39B | |
| Weighted average by Cap. | -0.94% | +6.08% | +42.76% | +64.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.94B 4.56B 4.26B 8.01B 534B 8.16B 54.73B 21.23B 263B 21.21B 20.73B 918B | 6.22B 5.44B 5.03B 4.69B 8.82B 588B 8.99B 60.28B 23.38B 290B 23.36B 22.83B 1,011B |
| Net income | 1.44B 1.26B 1.16B 1.08B 2.04B 136B 2.08B 13.93B 5.41B 67.04B 5.4B 5.28B 234B | 1.67B 1.47B 1.35B 1.26B 2.38B 158B 2.42B 16.23B 6.3B 78.08B 6.29B 6.15B 272B |
| Net Debt | -5.02B -4.39B -4.06B -3.79B -7.12B -475B -7.26B -48.66B -18.88B -234B -18.86B -18.43B -816B | -6.87B -6.02B -5.56B -5.18B -9.76B -651B -9.94B -66.64B -25.85B -321B -25.83B -25.24B -1,118B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$113.36 | -1.13% | 1,699,172 |
| 29/06/26 | US$114.66 | +0.80% | 1,532,380 |
| 26/06/26 | US$113.75 | +5.78% | 3,795,266 |
| 25/06/26 | US$107.53 | -0.86% | 1,832,481 |
| 24/06/26 | US$108.46 | +3.89% | 1,963,908 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
